昭衍新药(06127.HK)获易方达基金增持4.43万股

格隆汇
Feb 19

格隆汇2月19日丨根据联交所最新权益披露资料显示,2025年2月13日,昭衍新药(06127.HK)获易方达基金管理有限公司在场内以每股均价9.9953港元增持4.43万股,涉资约44.28万港元。

增持后,易方达基金管理有限公司最新持股数目为597.25万股,持股比例由4.98%上升至5.02%。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10